| Recruiting | Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma o NCT06630104 | Mayo Clinic | N/A |
| Recruiting | Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent NCT04883437 | Emory University | Phase 2 |
| Recruiting | Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymph NCT03258567 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer U NCT02861417 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Project: Every Child for Younger Patients With Cancer NCT02402244 | Children's Oncology Group | — |
| Completed | 3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma NCT02057445 | New York Medical College | Phase 1 |
| Completed | Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases NCT01447056 | Baylor College of Medicine | Phase 1 |
| Completed | Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma NCT01273090 | Children's Oncology Group | Phase 1 |
| Terminated | Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodyspl NCT01118013 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Terminated | Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Underg NCT01116232 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Recruiting | Registry of Older Patients With Cancer NCT01137825 | UNC Lineberger Comprehensive Cancer Center | — |
| Recruiting | 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer NCT00935090 | Barbara Ann Karmanos Cancer Institute | — |
| Recruiting | Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643 | UNC Lineberger Comprehensive Cancer Center | — |
| Terminated | Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders NCT00869323 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Terminated | Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer NCT00726830 | M.D. Anderson Cancer Center | N/A |
| Completed | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer NCT00823524 | Asan Medical Center | Phase 1 / Phase 2 |
| Completed | Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone NCT00993694 | Vanderbilt University | — |
| Terminated | Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunte NCT00952185 | City of Hope Medical Center | N/A |
| Completed | American Ginseng in Treating Patients With Fatigue Caused by Cancer NCT00719563 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Quality of Life in Younger Leukemia and Lymphoma Survivors NCT00956475 | Case Comprehensive Cancer Center | — |
| Completed | Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clin NCT00750009 | Case Comprehensive Cancer Center | Phase 3 |
| Completed | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma NCT00734890 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in NCT00516503 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Withdrawn | Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma NCT00621036 | University of Texas Southwestern Medical Center | Phase 2 |
| Completed | KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment NCT00646139 | Roswell Park Cancer Institute | Phase 1 |
| Terminated | Studying Fentanyl in Patients With Cancer NCT00899951 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Withdrawn | Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer NCT00499668 | Vanderbilt-Ingram Cancer Center | N/A |
| Completed | Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy NCT00416624 | Mayo Clinic | Phase 2 |
| Completed | Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases NCT00424242 | Northwestern University | EARLY_Phase 1 |
| Completed | Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or NCT00376922 | Wake Forest University Health Sciences | N/A |
| Withdrawn | Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive NCT00387530 | University of California, San Diego | Phase 2 |
| Completed | Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer NCT00661999 | Mayo Clinic | Phase 3 |
| Unknown | AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma NCT00324597 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Completed | Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment NCT00436618 | Mayo Clinic | Phase 2 |
| Completed | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer NCT00255749 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Completed | Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma NCT01000753 | Children's Oncology Group | — |
| Completed | Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain NCT00666211 | Vanderbilt-Ingram Cancer Center | Phase 3 |
| Completed | Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer NCT01147991 | Cancer Research UK | Phase 1 |
| Terminated | Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lympho NCT00093704 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of NCT00092222 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lym NCT00087009 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproli NCT00066469 | Children's Oncology Group | Phase 2 |
| Withdrawn | Collecting and Storing Blood Samples From Patients With Cancer NCT00900120 | University of Medicine and Dentistry of New Jersey | — |
| Completed | Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer NCT00070382 | Jonsson Comprehensive Cancer Center | Phase 3 |
| Completed | Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome NCT00065390 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Epoetin Alfa in Treating Anemia in Patients With Solid Tumors NCT00058331 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD NCT00278200 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer NCT00053053 | Radiation Therapy Oncology Group | Phase 3 |
| Completed | Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoprol NCT00033475 | University of Edinburgh | Phase 3 |
| Completed | Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome NCT00013689 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Treatment and Natural History Study of Lymphomatoid Granulomatosis NCT00001379 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Bloo NCT01101412 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |